Yet in 2020, half of all nonprofit hospitals reported charity care costs at 1.4 percent or less of operating expenses, with some reporting less than 0.1 percent. The gap between institutional wealth accumulation and direct patient financial relief is not a rhetorical device. It is a structural feature of how philanthropic capital moves through the American healthcare system.
That gap raises a basic allocation question: should donated dollars preserve institutional infrastructure over decades, or should they reach patients facing an immediate bill?
Two distinct mechanisms govern the answer. Hospital endowments lock principal capital into long-term investment vehicles, generating annual returns that support operations, research, facilities, and other institutional priorities. Patient relief funds operate on the opposite logic: they direct available money toward individuals facing acute medical costs. Both are forms of charitable hospital giving, but they work on different timelines, answer to different restrictions, and produce different kinds of measurable impact.
The Mechanics of Perpetual Capital: How Hospital Endowments Operate
An endowment is a long-term investment vehicle designed to preserve a pool of capital while using part of its returns to support an institution. Its principal may come from major donor gifts, planned-giving bequests, foundation grants, or institutional reserves. The governing premise is that the original capital remains invested rather than being spent all at once.
A hospital may use endowment distributions to support clinical departments, faculty positions, research programs, scholarships, capital equipment, or other named priorities. Depending on the gift agreement, the money may be restricted to a particular specialty or purpose. A donor who establishes a fund for cardiovascular research generally cannot have that gift redirected to a patient’s emergency treatment simply because the hospital later faces a surge in uncompensated care.
Endowments create financial continuity. Investment returns can provide a recurring source of revenue that is less dependent on the success of each annual fundraising campaign. That predictability matters to hospitals because research programs, clinical training, and specialized services require commitments that extend well beyond a single budget cycle.
The model also creates institutional capacity that can be difficult to fund through direct relief appeals. A research program may improve diagnosis or treatment over many years. A teaching fund may help sustain a pipeline of physicians, nurses, and other professionals. Capital equipment may expand the hospital’s ability to deliver care. These outcomes are indirect from the patient’s perspective, but they are not necessarily abstract or insignificant.
The difficulty lies in the distance between that long-term benefit and the person who needs help now. Endowment income usually enters an institutional budgeting process before it reaches a service line or program. Even an unrestricted fund is not automatically a patient-relief account. Hospital leadership, investment committees, donor agreements, and applicable state law all shape how the money can be used.
Endowment governance also reflects a preference for stability. Spending policies are designed to avoid exhausting the fund during a period of poor investment performance. The institution may therefore continue receiving support from an endowment without having unrestricted access to the full value of the underlying assets. This protects the fund’s future purchasing power, but it also limits the speed with which endowment assets can respond to a sudden humanitarian need.
Endowment capital is designed for institutional continuity. A patient relief fund is designed for the moment when a bill becomes an immediate threat.
The contrast is not simply between generosity and indifference. It is between two definitions of what a charitable dollar is supposed to accomplish. One preserves the capacity of an organization to operate and grow. The other reduces a burden already placed on an individual household.
Direct Intervention: The Role of Patient Relief Funds in Crisis
Patient relief funds are built around direct intervention. They provide financial assistance to people who cannot afford all or part of the cost of hospital care, often using household income, family size, insurance status, and the nature of the medical service as eligibility factors. Assistance may take the form of a bill reduction, a grant, payment toward a specific service, or support for related costs that make treatment possible.
Their defining feature is timing. The money is intended to be used when the cost event occurs, rather than invested for future institutional use. That makes patient relief funds particularly relevant to emergency treatment, serious illness, extended hospitalization, and other situations in which a household has little opportunity to reorganize its finances.
In practice, patient assistance can be administered through several channels:
- a hospital’s own financial assistance program;
- a donor-funded relief account;
- a foundation connected to the hospital;
- a disease-specific charitable organization;
- a social-work referral or community partnership;
- or a combination of these sources.
The funding may be restricted, but the restriction is usually closer to the patient than an endowment restriction is. A fund may be reserved for children, cancer treatment, transportation, medication, or patients below a specified income level. Those limits can improve targeting, but they can also exclude people whose needs do not fit the donor’s chosen category.
Patient relief funds have a clear limitation: money spent on one patient is no longer available for another. There is no compounding mechanism. The account must be replenished through new donations, annual allocations, grants, or institutional support. During an economic downturn, that can produce a particularly damaging mismatch. Patient need rises while fundraising becomes more difficult and household donors have less capacity to give.
This is the central distinction between endowment giving in healthcare and direct relief. Endowment capital is intended to generate a continuing stream of institutional support. Relief capital is intended to be used. Treating the second model as financially inefficient misses its purpose. The depletion of a relief fund is not evidence that it failed; it may indicate that the money reached the people for whom it was raised. The relevant question is whether the fund was replenished, fairly administered, and directed to needs that the hospital’s broader system failed to absorb.
The scale of the problem is substantial. Estimates of total U.S. medical debt range from $195 billion to $220 billion. Charitable assistance cannot eliminate that burden on its own, and even a well-funded patient relief program represents only a limited intervention against national medical debt. But the limited scale of a fund does not make its individual effects unimportant. A bill reduction can determine whether a patient delays follow-up care, loses access to medication, enters collections, or can keep up with ordinary household expenses.
Comparative Architecture: Endowments vs. Patient Relief Funds
The contrast becomes clearer when the two models are placed alongside each other.
| Dimension | Hospital Endowments | Patient Relief Funds |
|---|---|---|
| Capital timeline | Long-term or perpetual; principal is generally preserved | Immediate or short-term; funds are distributed as needs are approved |
| Spending pattern | Governed by investment and institutional spending policies | Governed by eligibility rules, available balances, and patient circumstances |
| Revenue predictability | More stable over time, though returns fluctuate with markets | More dependent on annual donations, grants, and budget decisions |
| Donor restrictions | May be tightly restricted to a department, program, or purpose | May be restricted by patient group, service, location, or financial need |
| Administrative work | Investment management, fiduciary oversight, reporting, and donor compliance | Eligibility review, documentation, billing coordination, and patient communication |
| Patient impact | Usually indirect; supports institutional capacity and services | Direct; reduces or pays part of an individual’s healthcare cost |
| Growth mechanism | Investment returns and additional contributions | New donations, grants, and institutional replenishment |
| Relevant oversight | Donor intent, investment policy, and state endowment law | Financial Assistance Policies, billing rules, grant terms, and internal procedures |
The table exposes an asymmetry that is easy to miss in broad discussions of charitable hospital donations. Endowments grow through time and investment. Relief funds are measured by what they can spend now. One appears stronger when the metric is balance-sheet durability; the other appears stronger when the metric is immediate household protection.
Neither model is automatically superior. A hospital without stable capital may struggle to maintain specialized services, recruit staff, or invest in research. A hospital with strong institutional finances but weak patient assistance may preserve its balance sheet while leaving people exposed to avoidable financial harm.
The more useful question is not whether a hospital should have endowments or relief funds. It is how the institution defines the relationship between them. Are endowment distributions counted as part of community benefit in a way that obscures the small amount reaching patients directly? Are unrestricted charitable dollars available for assistance, or do they disappear into general operating priorities? Can donors understand whether their gifts support a research program, a building, an endowment, or a patient’s bill?
These are not technical distinctions for finance departments alone. They determine what donors believe they are funding and what patients can reasonably expect to receive.
The Disconnect Between Institutional Wealth and Charity Care Spending
A 2023 analysis examining 2,219 nonprofit hospitals from 2012 through 2019 found that as financial earnings grew, hospital cash reserves increased while charity care spending did not rise proportionally. The implication is structural rather than purely moral. Institutional financial behavior tends to favor reserves, asset accumulation, and long-term planning, while charity care does not automatically expand at the same rate as profitability.
That pattern matters because nonprofit hospital status is justified through the delivery of community benefit. The public gives up tax revenue on the understanding that the institution provides value beyond ordinary commercial activity. Charity care is only one part of that community benefit, but it is the part most directly connected to patients who cannot pay.
The figures from 2020 illustrate the tension. Half of nonprofit hospitals reported charity care costs at 1.4 percent or less of operating expenses. Some reported less than 0.1 percent, while others exceeded 7 percent. The range is wide, and hospitals differ in patient population, service mix, geography, payer structure, and local economic conditions. A single percentage cannot capture every form of community benefit or determine whether a hospital is meeting its responsibilities.
Still, the distribution raises a serious allocation issue. If institutional reserves and endowment assets expand while direct charity care remains a marginal expense, then the existence of financial capacity does not guarantee the availability of financial assistance. The hospital may be financially strong and still make relief difficult to access.
This is where restricted vs. unrestricted hospital giving becomes consequential. Restricted donations can produce meaningful benefits, but their use is bounded by the donor’s instructions. A fund for a new oncology center may improve treatment capacity without paying the bill of an uninsured oncology patient. A scholarship endowment may strengthen the future workforce without helping a current family manage a hospital balance. Those outcomes can coexist, but they should not be presented as interchangeable.
Unrestricted donations offer greater flexibility, yet they also compete with every other institutional priority. Leaders may direct them toward staffing, maintenance, technology, debt service, or strategic expansion. Those decisions may be reasonable from an operational perspective. They do not necessarily answer the question of whether a patient facing financial hardship received timely assistance.
The tax exemption framework therefore depends on more than the existence of charitable programs. It depends on transparency about where the benefits go. A hospital that reports substantial community investment should be able to distinguish between money that strengthens the institution and money that directly reduces the cost of care for individuals.
Navigating Financial Assistance Policies: Why Awareness Remains a Barrier
The availability of a financial assistance program is a necessary but insufficient condition for its use. Survey data from the Patient Access Network Foundation indicates that only 24 percent of patients with chronic conditions reported familiarity with financial assistance programs, while 37 percent reported needing financial support.
That gap is not merely a communications problem. It is an access problem. A patient cannot apply for assistance that they do not know exists, and a family under financial pressure may not have the time, confidence, or documentation required to interpret a hospital’s policy.
Federal requirements under Section 501(r) of the Internal Revenue Code require tax-exempt hospitals to establish and widely publicize Financial Assistance Policies. Those policies generally explain eligibility, the application process, the types of assistance available, and the billing limitations that apply to eligible patients. The existence of a policy, however, does not guarantee that the policy is understandable or offered at the right moment.
In practice, information may be buried in admissions documents, placed on a website alongside dense billing language, or sent after a patient has already received a statement. Staff members may use different terms for charity care, discounts, payment plans, and external assistance. A patient may also assume that having insurance disqualifies them, even when the policy allows help with remaining costs.
The pathway from eligibility to assistance often involves several separate steps:
1. Recognition: The patient must learn that financial assistance may be available.
2. Screening: The hospital or an assisting organization must determine whether the patient may qualify.
3. Documentation: The applicant may need to provide income, household, insurance, or residency information.
4. Application: The request must be submitted through the hospital’s required process.
5. Adjudication: The institution must review the request under the relevant policy.
6. Billing correction: Approved assistance must be applied to the account and reflected in later statements.
A failure at any stage can leave the patient paying more than the policy requires. The problem may be procedural rather than intentional, but its financial effect is real.
The legal point also requires precision. Patients who meet a hospital’s criteria for free care may be eligible to have qualifying charges reduced to zero under that policy. Patients who qualify for discounted care may still owe a remaining balance. Eligibility does not mean that every medical bill disappears, and a Financial Assistance Policy is not a universal prohibition on medical debt.
Patients may nevertheless incur debt when assistance is not identified, when an application is incomplete, when documentation is delayed, or when an approved adjustment is not properly applied to the account. Some may also be unaware that they can request a review after receiving a bill or after an account has entered collections. In those cases, the failure is not that the patient was legally guaranteed free care. It is that an available mechanism was not successfully connected to the person who needed it.
A financial assistance policy has limited value if the patient encounters it only after the account has already become a collection problem.
Hospitals can reduce that friction through presumptive eligibility screening, plain-language notices, multilingual communication, staff referrals, and consistent coordination between admissions, social work, and billing. Automated screening can help identify patients who may qualify, but automation is not a substitute for a clear explanation or a straightforward appeal process. Patients need to know what information is being used, what assistance is available, and how to challenge an incorrect determination.
Better communication also protects donor intent. Someone who gives to a patient relief fund generally expects the money to produce patient relief, not to disappear into an opaque administrative pathway. Reporting should therefore show more than the total amount raised. It should explain how many patients were assisted, what types of expenses were covered, how long decisions took, and whether eligible patients were denied because of procedural barriers.
Balancing Future Stability with Urgent Humanitarian Needs
The tension between endowments and patient relief funds is not a binary choice between long-term planning and compassion. Both serve legitimate functions within healthcare philanthropy.
Endowment capital can preserve research capacity, clinical infrastructure, education, and workforce development through economic cycles. Patient relief funds can prevent a single episode of illness from destabilizing a household. The first protects an institution’s future operating capacity; the second protects a patient’s present ability to pay for care and remain financially functional.
The policy question is one of proportion and accountability. At current allocation levels, institutional accumulation appears to be better protected than direct patient relief. The evidence on charity care spending does not show that every hospital is failing its community, but it does show that financial strength alone does not ensure proportional assistance for patients.
Several changes could narrow the gap without dismantling the endowment model.
Connect community-benefit expectations to institutional capacity
Hospitals with substantial reserves, endowment income, and operating revenue should explain how those resources relate to direct charity care and financial assistance. A simple aggregate community-benefit figure is not enough. Donors, regulators, and patients need to see the difference between capital investment, research support, subsidized services, and reductions applied to patient accounts.
A more meaningful reporting framework would place charity care alongside the institution’s financial capacity rather than presenting it in isolation. That would not require treating every dollar of endowment assets as immediately spendable. It would require making the allocation logic visible.
Make assistance automatic where possible
Hospitals should identify likely eligibility early in the care and billing process rather than waiting for a patient to find the policy independently. Presumptive screening, plain-language notices, and referrals from clinicians or social workers can reduce the burden on patients who are already dealing with illness.
Automation should be paired with human review. Income data can be incomplete, households can have irregular earnings, and a temporary crisis may not be reflected in a standard document. A patient should be able to explain circumstances that a rigid screening process cannot capture.
Protect unrestricted relief capacity
Donors should be given a clear choice between restricted institutional gifts and unrestricted patient assistance. Hospitals, in turn, should preserve some flexible funding for needs that do not fit a named program. A patient relief fund that can respond only to one diagnosis, one age group, or one type of expense may leave serious gaps even when it is well funded.
Endowment returns may sometimes support relief, but that possibility depends on donor restrictions, governing documents, investment policy, and applicable law. Flexibility should be built into future gift agreements where donors intend their contributions to support community access as conditions change. It cannot simply be assumed that an existing restricted endowment can be repurposed during a crisis.
Measure relief as an outcome, not only as an expense
A hospital should track whether approved assistance reached the account, whether the patient received the decision before collections activity, and whether the process reduced avoidable delays. The amount distributed matters, but so do approval times, denial reasons, appeal outcomes, and the share of eligible patients who were screened.
That approach treats patient relief as a service with an accountable delivery system rather than a discretionary act of generosity. It also gives donors a better understanding of patient relief fund impact.
The national medical debt burden, estimated at $195 billion to $220 billion, will not be solved by charitable giving alone. Hospitals cannot use philanthropy as a substitute for broader reform in pricing, insurance coverage, billing, and public policy. But that limitation should not become an excuse for leaving available assistance difficult to find or narrowly defined.
The most defensible approach to hospital endowments vs patient relief funds is not to reject perpetual capital. It is to stop treating long-term institutional strength as proof that immediate patient needs have been met. Endowments and relief funds should be evaluated according to the problems they are meant to solve, with transparent boundaries between them.
Endowment giving in healthcare can preserve capacity that patients will need in the future. Patient relief funds can prevent today’s care from becoming tomorrow’s financial crisis. A responsible charitable hospital system needs both—but it also needs to show, in concrete terms, how much of its philanthropic capital reaches the patient ledger, how quickly it gets there, and who is still being left outside the process.